Skip to main content
. Author manuscript; available in PMC: 2024 May 1.
Published in final edited form as: Value Health. 2022 Oct 8;26(5):676–684. doi: 10.1016/j.jval.2022.09.002

Table 4.

The effect of non-complex NFFCCM intensity on healthcare utilization

6-month treatment 12-month treatment
1-5 visits 6+ visits 6+ vs 1-5 1-10 visits 11+ visits 11+ vs 1-10
All-cause utilization (visits per month)
Outpatient 0.458*** 0.640*** 0.134* 0.312*** 0.578*** 0.186*
[0.423,0.494] [0.603,0.676] [0.006,0.263] [0.269,0.354] [0.536,0.619] [0.035,0.337]
<0.001 <0.001 0.040 <0.001 <0.001 0.016
Inpatient 0.003 0.002 −0.004 0.003 −0.001 −0.002
[−0.000,0.006] [−0.001,0.005] [−0.015,0.007] [−0.001,0.006] [−0.004,0.003] [−0.015,0.010]
0.096 0.312 0.519 0.166 0.647 0.710
ED −0.004* −0.010*** −0.005 0.000 −0.001 0.000
[−0.008,−0.000] [−0.014,−0.007] [−0.016,0.006] [−0.006,0.005] [−0.005,0.003] [−0.015,0.015]
0.033 <0.001 0.365 0.881 0.689 0.966
Any inpatient admissions or ED visits related to
CHD −0.004 0.010* 0.019 0.010* 0.005 −0.002
[−0.013,0.005] [0.000,0.019] [−0.014,0.052] [0.001,0.020] [−0.005,0.014] [−0.036,0.031]
0.406 0.044 0.249 0.037 0.333 0.899
Stroke −0.001 0.004 0.007 −0.006** 0.001 0.007
[−0.005,0.003] [−0.000,0.009] [−0.009,0.023] [−0.009,−0.002] [−0.003,0.005] [−0.006,0.020]
0.740 0.059 0.371 0.002 0.587 0.295
MACE −0.003 0.002 0.013 0.007 0.001 −0.002
[−0.013,0.006] [−0.008,0.011] [−0.021,0.047] [−0.003,0.017] [−0.009,0.010] [−0.035,0.032]
0.480 0.706 0.443 0.201 0.916 0.923
N treatment 660 687 679 510 553 551
N control 17,636 17,505 660 13,958 13,906 506
N total 18,296 18,192 1,339 14,468 14,459 1,057

Notes: NFFCCM: non-face-to-face chronic care management. ED: emergency department. CHD: coronary heart disease. MACE: major adversed cardiovascular disease. For each outcome, the coefficient is listed and followed with its 95% confidence interval and p value. * p< 0.05, ** p< 0.01, *** p< 0.001.